Monthly Archives: November 2014

Police have charged the man with delivery of a controlled substance. The woman hasn’t been charged. Paramedics on Monday and Tuesday responded to cases in an east area of downtown Austin. They say most of the people were homeless and had either become violent or lost consciousness after using the drug. Police say they used surveillance video to identify the suspects and that officers seized 4 grams of the drug from a hotel room where they were staying. They say the drug was laced with five illegal chemicals. The suspects’ identities haven’t been released. Copyright 2014 by The Associated Press – All rights reserved. For the original version including any supplementary images or video, visit http://www.ksat.com/content/pns/ksat/news/2014/11/19/2-arrested–12-sickened-in-synthetic-marijuana-case.html

Hartford health center nets mental health grant Watertown’s Theraplant said Monday that it is the first of the state’s four licensed medical marijuana producers to deliver extracts to dispensaries. Delivery of the one-gram bottles of the highly concentrated liquid took place Friday, according to Theraplant, which says it supplies all six of the state’s licensed dispensaries. In September, Theraplant was also the first grower to deliver to dispensaries homogenized raw flower, pre-rolled cones and tablets. Dispensaries are awaiting crops from the other licensed growers, who have said they hope to deliver by year’s end. With supply limited, prices have been somewhat high. For the original version including any supplementary images or video, visit http://www.hartfordbusiness.com/article/20141124/NEWS01/141129971

Police have charged the man with delivery of a controlled substance. The woman hasn’t been charged. Paramedics on Monday and Tuesday responded to cases in an east area of downtown Austin. They say most of the people were homeless and had either become violent or lost consciousness after using the drug. Police say they used surveillance video to identify the suspects and that officers seized 4 grams of the drug from a hotel room where they were staying. They say the drug was laced with five illegal chemicals. For the original version including any supplementary images or video, visit http://www.news-journal.com/news/police/police-arrested-in-austin-synthetic-marijuana-case/article_4eec25d8-6ff3-11e4-93e5-43bc9e1cf0f0.html

In December 2007, Chris spotted one in the Journal of Lipid Research. Scientists at the University of Texas Southwestern Medical School kept a colony of mice with a version of Niemann-Pick disease. When they were treated with a compound called cyclodextrin, the animals lived nearly twice as long. Cylclodextrin is a form of sugar. It’s used in consumer products like detergent and air freshener because it can bind to odor-causing molecules. In the pharmaceutical industry, it is sometimes used as an excipient: a delivery vehicle to mix with an active ingredient. For the original version including any supplementary images or video, visit http://www.cnn.com/2014/11/21/health/hempels-genetic-disorder-niemann-pick/index.html

About WeedHire International (OTCBB:WDHR) WeedHire International is the parent company of WeedHire.com , a career website specifically targeting employment within the legal cannabis industry. Our mission is to help our clients hire the most qualified individuals and to help those individuals find the best job opportunities in their respective fields furthering their careers in legal marijuana. WeedHire.com provides job postings for cannabis jobs such as Recommending physicians, Physician’s assistants, Growers, Budtenders, Dispensary operators, Security guards, Dispensary administrators, Lighting specialist, Delivery drivers, Lab techs, Marketing specialists, Lawyers, Insurance agents and Government jobs. In addition, the specialized focus of our website benefits those job seekers by helping to ensure that the job opportunities posted by our customers are relevant and attractive to them. Safe Harbor Statement This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results or implied by such statements. These factors include, but are not limited to, our ability to comply with the laws, rules and regulations related to medical marijuana, our ability to identify and consummate business combinations, our ability to raise sufficient capital to fund our business, operations and any business combinations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. AnythingIT Inc.’s future results may also be impacted by other risk factors listed from time to time in its SEC filings. Many factors are difficult to predict accurately and are generally beyond the company’s control. Forward-looking statements speak only as to the date they are made and AnythingIT, Inc. For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/weedhire-international-formerly-anythingit-inc-140000585.html

Allen Peake, R-Macon, speaks on behalf of his bill that would legalize medical marijuana in Georgia for patients with certain illnesses, in Atlanta in this March 3, 2014, file photo. Photo by Associated Press /Chattanooga Times Free Press. ATLANTA While an effort to bring a form of medical marijuana to Georgia garnered bipartisan support during the most recent legislative session, hurdles remain as lawmakers prepare to make another attempt at passing the legislation next year. A bill is being drafted after a series of committee hearings and included testimony from leaders within the law enforcement and medical communities who raised concerns about the use of medical cannabis even under narrow circumstances. Meanwhile, progress is being made in terms of bringing clinical trials to Georgia, but advocates warn that will not be enough to help all those who see the drug as their best hope to manage debilitating conditions. “I don’t think any of us are opposed to finding out how effective it is or how it works, but let’s have compassionate use with it as well,” said Bob Kutchback, whose young granddaughter suffers from a rare disorder that causes severe seizures. Rep. For the original version including any supplementary images or video, visit http://www.timesfreepress.com/news/2014/nov/17/georgia-lawmakers-press-forward-medical-cannabis/

Costs to develop, manufacture, and commercialize the products will be borne by CannScience. Since 2001, qualifying Canadians have been able to access medicinal cannabis through the Marihuana Medical Access Regulations (MMAR) program. In response to a handful of concerns, on April 1, 2014, the MMAR system was repealed and replaced with the Marihuana for Medical Purposes Regulations (MMPR) program (which came into effect on October 1, 2013), where all medicinal cannabis must be produced and procured a Licensed Producer (LP), effectively commercializing the medicinal cannabis industry in Canada. Health Canada projects a total market of $1.3 billion by 2024 under the new MMPR system, representing a growth in number of patients of 36% CAGR over the coming five years and a further 10% CAGR over the following five years. Further, products developed through this co-development arrangement may potentially be commercialized in international markets. In legalized marijuana markets such as Colorado, derivative product market segments have demonstrated the fastest growth as the markets become established. CannScience is an R&D biopharmaceutical company established in Toronto, Canada to conduct research and product development for formulations and extracts related to medical cannabis and its derivatives. For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/generex-announces-collaboration-medicinal-cannabis-143000626.html

The amount of the psychoactive compound known as tetrahydrocannabinol, or THC, would be limited and facilities would be subject to regulations, lab testing and security measures. “I feel very confident that my colleagues want to move forward with a public policy that provides a very tightly restricted, very regulated delivery system for cannabis oil in Georgia,” Peake said, adding he’s aware of 15 families who have left Georgia for Colorado and other states for access to the cannabis oil and three children have died while lawmakers have been debating the issue. “We can’t move fast enough.” Law enforcement’s top concerns include security at the facilities and specific civil and criminal penalties for violators. The Georgia Sheriffs’ Association also indicated they would oppose a bill if law enforcement agencies weren’t granted warrantless access to the facilities for monitoring. Association President, Decatur County Sheriff Wiley Griffin, said members worry the bill could send mixed messages to the public. “We want to be there to help,” Griffin said at an Oct. 1 hearing. “That is our job to help people, but we are also very, very concerned about the perception that this bill would lead to people thinking you could smoke marijuana for medical purposes.” Peake said he feels confident the bill will address those concerns. For the original version including any supplementary images or video, visit http://www.news4jax.com/news/georgia-news/ga-lawmakers-press-forward-on-medical-cannabis/29753992

in that the ultimate decision as to which applicant will be approved is left to chance, rather than logic and an evaluation of all necessary facts,” he wrote. “Assuring the dependable delivery of consistently high-quality, low-THC medicine is too important to be left to chance. Rather than minimally qualified applicants, citizens of the State of Florida, including sick and vulnerable children, deserve approval of the most qualified growers, processors and dispensers of low-THC cannabis,” Watkins wrote. Health officials claimed that using the lottery system would reduce potentially drawn-out litigation over the selection of the five dispensing organizations and refused to back down from the selection process despite protests from nursery owners at public hearings where the rule was vetted. But Watkins said the Department of Health needs to pick the most-qualified applicants to grow and process marijuana low in euphoria-inducing tetrahydrocannabinol, or THC, and high in cannabidiol, or CBD. The Legislature intended for the low-THC cannabis to be “reasonably available and accessible to patients needing this medicine,” Watkins wrote. “The evidence adduced at hearing supports the common sense notion that this objective requires selecting the most dependable, most qualified dispensing organizations to cultivate, process, and dispense low-THC cannabis as prescribed by physicians. The proposed lottery rule to select these special franchises by chance creates risks that substantially reduce the likelihood of this objective being met,” Watkins wrote. Supporters of the low-THC, high-CBD strains of cannabis believe the substance can eliminate or dramatically reduce life-threatening seizures in children with severe forms of epilepsy. Under the new law, patients with other spasm-causing diseases or cancer would also be eligible for the strains of marijuana if their doctors order it, and if their doctors say they have exhausted all other treatments. For the original version including any supplementary images or video, visit http://www.news4jax.com/news/judge-strikes-down-pot-rule/29730918